Valuation Through A Health Lense & What Professional Investors Look For When Investing

Join us for an overview of health-focused company valuation methods by a valuation expert, followed by a walk-through of the decision making process used by seasoned investors when they invested early (and subsequently followed-on) in one of Norway’s most successful biotech companies, Vaccibody.

– Vaccibody just secured the largest Biotech deal Norway has ever seen.

Moderator: Jeremy McCrohan, Norwegian Health Investor Network (Head of Investor Relations, Norway Health Tech)